Skip to main content
main-content
Oncology

Catch-up HPV vaccination supported in older adolescence

Vaccine injection

US researchers have found evidence to support catch-up vaccination against the human papillomavirus in women given their first dose in older adolescence.

Rheumatology

TNF inhibitors unlikely to raise cancer recurrence risk in RA patients

Needle

Treatment with tumour necrosis factor inhibitors is not associated with a significantly increased risk of recurrent cancer among patients with rheumatoid arthritis, researchers report.

Respiratory

Proportion of asthma patients who could benefit from anti-IL-5 treatment estimated

Antibodies

Researchers estimate that 2% of patients with adult-onset eosinophilic asthma could benefit from treatment involving antibodies against the interleukin-5 pathway.

HBV

Global HBV prevalence estimated at 3.9%

World map

More than 290 million people, or 3.9% of the global population, are infected with hepatitis B virus, and while efforts to combat infection are improving, greater access to diagnosis and treatment is needed to meet global targets, report The Polaris Observatory Collaborators.

Headlines from across medwireNews

17-08-2018 | Non-small-cell lung cancer | News | Article

Third-line anlotinib boosts advanced NSCLC survival

The multikinase inhibitor anlotinib is effective and well tolerated in advanced non-small-cell lung cancer patients who have used at least two prior lines of systemic therapy, phase III trial results suggest.

17-08-2018 | Rheumatology | News | Article

Intensive treatment in early arthritis patients provides long-term remission benefits

Short-term induction therapy with a tumor necrosis factor inhibitor plus methotrexate could alter disease development in some patients with early rheumatoid arthritis, providing long-term benefit, results of the DINORA trial suggest.

16-08-2018 | Skin cancer | News | Article

Brief dermatologist-delivered intervention may improve sun protection behavior

The Addressing Behavior Change intervention, which can be delivered by dermatologists in less than 3 minutes, is associated with improvements in people’s sun protection behavior that last several months, findings indicate.

16-08-2018 | Neurology | News | Article

Recognising the risk of increased suicide following TBI

Findings from a large registry-based study support an increased risk of suicide following traumatic brain injury.

16-08-2018 | Rheumatology | News | Article

Predictors of remission in RA patients identified

Two studies have described factors associated with the achievement of sustained remission among patients with rheumatoid arthritis.

15-08-2018 | Oncology | News | Article

Apatinib–etoposide shows promise in platinum-resistant ovarian cancer

Oral etoposide plus apatinib is associated with a good objective response rate and manageable toxicity in heavily pretreated Chinese women with platinum-resistant or refractory ovarian cancer, according to results of the phase II AEROC study.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make medwireNews.com your preferred medical news resource.

Meet the team

image credits